Targeting Mitochondrial Integrity as a New Senolytic Strategy

Area of Science:

• Gerontology and Cellular Biology
• Mitochondrial Medicine
• Drug Delivery Systems

Background:

• Aging is characterized by the accumulation of senescent cells, driving age-related diseases.
• Senescent cells pose significant global health risks due to increasing prevalence and complications.
• Reducing senescent cells is a promising strategy for promoting healthy aging.

Purpose of the Study:

• To investigate the selective elimination of senescent cells by targeting tamoxifen to mitochondria.
• To elucidate the mechanism of senescent cell death induced by mitochondrially targeted tamoxifen.
• To evaluate the potential of this strategy for promoting healthy aging.

Main Methods:

• Mitochondrial targeting of tamoxifen using triphenyl and tricyclohexyl phosphine.
• Assessment of mitochondrial function and integrity in senescent cells.
• Analysis of cell death pathways, including ferroptosis activation.

Main Results:

• Mitochondrially targeted tamoxifen selectively eliminated senescent cells.
• The compound induced complex effects on mitochondrial function, inhibiting oxidative phosphorylation and respiratory complex IV.
• Activation of ferroptosis was identified as the primary mode of cell death, leading to tissue rejuvenation.

Conclusions:

• Targeting mitochondria of senescent cells is a viable senolytic strategy.
• This approach can lead to tissue rejuvenation and may improve quality of life in aging populations.
• Mitochondrially targeted tamoxifen shows potential for extending healthspan.